HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.

Abstract
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited response to immunomodulatory therapies, decreased quality of life and, potentially, early death. Idiopathic pulmonary fibrosis may be regarded as a model for other progressive-fibrosing ILDs. Here we focus on other ILDs that may present a progressive-fibrosing phenotype, namely idiopathic nonspecific interstitial pneumonia, unclassifiable idiopathic interstitial pneumonia, connective tissue disease-associated ILDs (e.g. rheumatoid arthritis-related ILD), fibrotic chronic hypersensitivity pneumonitis, fibrotic chronic sarcoidosis and ILDs related to other occupational exposures. Differential diagnosis of these ILDs can be challenging, and requires detailed consideration of clinical, radiological and histopathological features. Accurate and early diagnosis is crucial to ensure that patients are treated optimally.
AuthorsVincent Cottin, Nikhil A Hirani, David L Hotchkin, Anoop M Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K Poonyagariyagorn, Wim Wuyts, Athol U Wells
JournalEuropean respiratory review : an official journal of the European Respiratory Society (Eur Respir Rev) Vol. 27 Issue 150 (Dec 31 2018) ISSN: 1600-0617 [Electronic] England
PMID30578335 (Publication Type: Journal Article, Review)
CopyrightCopyright ©ERS 2018.
Topics
  • Adult
  • Aged
  • Diagnosis, Differential
  • Disease Progression
  • Female
  • Humans
  • Lung (diagnostic imaging, physiopathology)
  • Lung Diseases, Interstitial (diagnosis, mortality, physiopathology, therapy)
  • Male
  • Middle Aged
  • Phenotype
  • Predictive Value of Tests
  • Pulmonary Fibrosis (diagnosis, mortality, physiopathology, therapy)
  • Quality of Life
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: